Back to Search
Start Over
[Anti DIC therapy].
- Source :
-
Nihon rinsho. Japanese journal of clinical medicine [Nihon Rinsho] 2016 Feb; Vol. 74 (2), pp. 257-61. - Publication Year :
- 2016
-
Abstract
- A variety of disorders erratically activate coagulation cascades. The disseminated intravascular coagulation (DIC) is caused by unbalanced activation between coagulation and fibrinolysis. Some of auxiliary treatments for DIC on top of main therapy against causative disease are beneficial in terms of better outcome. The anticoagulation therapy is indicated when an activation of coagulation dominates in DIC caused by sepsis. Whereas in DIC associated with trauma, since balance between coagulation and fibrinolysis collapses drastically in a short period, both anticoagulantion therapy and antifibrinolytic therapy can be utilized depending on clinical conditions. There are quite a few of anti DIC agents in Japan. It is imperative to choose appropriate agents to treat DIC taking their pharmacological properties into account.
- Subjects :
- Anticoagulants therapeutic use
Antifibrinolytic Agents therapeutic use
Antithrombins therapeutic use
Benzamidines
Disseminated Intravascular Coagulation diagnosis
Disseminated Intravascular Coagulation etiology
Gabexate therapeutic use
Guanidines therapeutic use
Heparin therapeutic use
Humans
Protease Inhibitors therapeutic use
Recombinant Proteins
Sepsis complications
Systemic Inflammatory Response Syndrome complications
Thrombomodulin therapeutic use
Tranexamic Acid therapeutic use
Wounds and Injuries complications
Disseminated Intravascular Coagulation drug therapy
Subjects
Details
- Language :
- Japanese
- ISSN :
- 0047-1852
- Volume :
- 74
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Nihon rinsho. Japanese journal of clinical medicine
- Publication Type :
- Academic Journal
- Accession number :
- 26915249